Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Apr 30, 2025 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.69%10.46B | -16.96%10.97B | -23.74%2.52B | -25.93%2.58B | -11.69%2.84B | -5.53%3.03B | 13.34%13.21B | 0.66%3.3B | 17.32%3.49B | 20.45%3.22B |
| Cost of revenue | -4.13%8.47B | -17.92%8.83B | -23.25%2.08B | -22.87%2.11B | -19.61%2.26B | -4.86%2.38B | 21.46%10.76B | 6.95%2.71B | 18.48%2.73B | 36.55%2.81B |
| Gross profit | -7.02%1.99B | -12.76%2.14B | -25.92%440.44M | -37.00%475.48M | 43.06%582.59M | -7.91%642.71M | -12.36%2.45B | -20.61%594.57M | 13.29%754.71M | -33.64%407.23M |
| Operating expense | 4.12%1.17B | -22.87%1.13B | -27.34%255.87M | -20.56%289.41M | -22.53%297.05M | -21.21%283.71M | 12.39%1.46B | 6.48%352.13M | 12.20%364.29M | 11.94%383.46M |
| Operating profit | -19.37%818.49M | 2.08%1.02B | -23.87%184.57M | -52.34%186.07M | 1,101.08%285.53M | 6.26%359M | -33.78%994.49M | -42.03%242.44M | 14.33%390.42M | -91.23%23.77M |
| Net non-operating interest income (expenses) | 265.26%9.36M | -89.84%2.56M | -94.55%538K | -84.79%574K | -78.66%777K | -91.51%673K | 171.17%25.21M | 257.83%9.87M | 129.90%3.78M | 13.39%3.64M |
| Non-operating interest income | 247.11%9.36M | -89.47%2.7M | -94.49%548K | -84.50%599K | -78.14%819K | -90.93%730K | 151.86%25.6M | 240.88%9.94M | 109.15%3.87M | 8.33%3.75M |
| Non-operating interest expense | --0 | -65.73%134K | -85.92%10K | -72.22%25K | -60.38%42K | -54.03%57K | -54.95%391K | -55.06%71K | -56.31%90K | -57.26%106K |
| Net investment income | 20.97%81.43M | 50.02%67.32M | 0 | 75.43%32.73M | 0 | 41.12%34.58M | 60.40%44.87M | 467.97%1.6M | 10.19%18.66M | 104.94%110K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -67.37%1.91M | -63.67%5.85M | -69.16%2M | 10.18%2.44M | -59.41%2.18M | -136.73%-756K | -8.15%16.11M | -16.37%6.49M | -37.68%2.21M | 10.79%5.36M |
| Special income (charges) | -99.69%2.17M | 75.12%691.32M | -99.63%1.13M | -98.61%1.49M | 4,378.97%20.87M | 3,619.53%667.83M | 394.77M | 306.05M | 107.23M | 466K |
| Less:Other special charges | 99.69%-2.17M | -67.33%-691.32M | 99.63%-1.13M | ---1.49M | ---20.87M | ---667.83M | ---413.16M | ---305.93M | ---- | ---- |
| Less:Write off | ---- | --0 | --0 | ---- | ---- | --0 | --18.39M | ---121K | --0 | ---466K |
| Other non-operating income (expenses) | -47.79%18.32M | 59.54%35.09M | 6.41%7.78M | 257.53%13.09M | -40.54%2.37M | 68.40%11.85M | 12.29%21.99M | 187.46%7.31M | -43.33%3.66M | -26.32%3.98M |
| Income before tax | -48.73%931.68M | 21.36%1.82B | -65.84%196.02M | -55.05%236.39M | 735.04%311.73M | 197.77%1.07B | -3.35%1.5B | 32.50%573.76M | 43.38%525.96M | -86.78%37.33M |
| Income tax | -40.28%223.39M | -7.70%374.05M | -32.43%62.15M | -43.35%70.22M | 70.35%92.1M | 10.60%149.59M | -13.20%405.24M | -27.92%91.98M | 15.06%123.96M | -43.54%54.06M |
| Net income | -50.92%708.3M | 32.14%1.44B | -72.21%133.87M | -58.66%166.17M | 1,412.72%219.63M | 310.20%923.59M | 0.90%1.09B | 57.74%481.78M | 55.15%402M | -108.97%-16.73M |
| Net income continuous operations | -50.92%708.3M | 32.14%1.44B | -72.21%133.87M | -58.66%166.17M | 1,412.72%219.63M | 310.20%923.59M | 0.90%1.09B | 57.74%481.78M | 55.15%402M | -108.97%-16.73M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -50.92%708.3M | 32.14%1.44B | -72.21%133.87M | -58.66%166.17M | 1,412.72%219.63M | 310.20%923.59M | 0.90%1.09B | 57.74%481.78M | 55.15%402M | -108.97%-16.73M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -50.92%708.3M | 32.14%1.44B | -72.21%133.87M | -58.66%166.17M | 1,412.72%219.63M | 310.20%923.59M | 0.90%1.09B | 57.74%481.78M | 55.15%402M | -108.97%-16.73M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -49.61%535.66 | 32.15%1.06K | -72.21%98.62 | -58.66%122.4 | 1,413.23%161.79 | 310.23%680.29 | 0.90%804.45 | 57.74%354.85 | 55.15%296.09 | -108.97%-12.32 |
| Diluted earnings per share | -49.61%535.66 | 32.15%1.06K | -72.20%98.6105 | -58.65%122.4 | 1,412.72%161.732 | 310.23%680.29 | 0.90%804.45 | 57.74%354.7739 | 55.15%296.0221 | -108.97%-12.3203 |
| Dividend per share | 0.00%80 | 0.00%80 | 0.00%80 | 0 | 0 | 0 | -20.00%80 | -20.00%80 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |